Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Rectum”

2,614 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,614 results

Early research (Phase 1)Study completedNCT00433576
What this trial is testing

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumStage I Colon Cancer+5 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00685568
What this trial is testing

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Who this might be right for
Colorectal CancerPrecancerous Condition
M.D. Anderson Cancer Center 22
Not applicableNot Yet RecruitingNCT07414082
What this trial is testing

Serum Talin-1 and Cripto-1 in Colorectal Cancer

Who this might be right for
Colo-rectal Cancer
Assiut University 70
Not applicableStudy completedNCT00410579
What this trial is testing

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Who this might be right for
Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more
NSABP Foundation Inc 744
Not applicableUnknownNCT04710589
What this trial is testing

CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer

Who this might be right for
Recurrent Rectal Cancer125I Seeds ImplantationClinical Target Volume
Peking University Third Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00025350
What this trial is testing

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT03297710
What this trial is testing

TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Rectal AdenocarcinomaRecurrent Rectal CarcinomaStage IV Rectal Cancer AJCC v7+2 more
Mayo Clinic 7
Not applicableLooking for participantsNCT05853094
What this trial is testing

Postoperative Effects of Different Enterostomy Approaches

Who this might be right for
Colorectal CancerColorectal Neoplasms MalignantIntestinal Neoplasms, Malignant
Fudan University 300
Not applicableStudy completedNCT00625066
What this trial is testing

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

Who this might be right for
Colorectal CancerPrecancerous Condition
Vanderbilt University 8,108
Testing effectiveness (Phase 2)Study completedNCT00613080
What this trial is testing

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Radiation Therapy Oncology Group 79
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Study completedNCT03443661
What this trial is testing

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Aiping Zhou 50
Testing effectiveness (Phase 2)Ended earlyNCT01198548
What this trial is testing

High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer

Who this might be right for
Stage IV Colon CancerStage IV Rectal Cancer
Roswell Park Cancer Institute 10
Not applicableStudy completedNCT02460822
What this trial is testing

Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management

Who this might be right for
Colon CancerRectal Cancer
University of Michigan 16
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Testing effectiveness (Phase 2)WithdrawnNCT00002664
What this trial is testing

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
James Ahlgren
Early research (Phase 1)Study completedNCT01407107
What this trial is testing

Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer

Who this might be right for
Rectal Cancer
University of Texas Southwestern Medical Center 13
Not applicableStudy completedNCT02153801
What this trial is testing

Genito Urinary Function With High or Low Inferior Mesenteric Artery Ligation in Laparoscopic Anterior Rectal Resection

Who this might be right for
Genito Urinary Function Evaluation
Niguarda Hospital 212
Not applicableUnknownNCT04012645
What this trial is testing

Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR

Who this might be right for
Rectal Neoplasms
Zhongtao Zhang 547
Early research (Phase 1)Study completedNCT00532909
What this trial is testing

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Who this might be right for
Anal, Colon, and Rectal CancersColorectal NeoplasmsColon/Rectal Cancer
Branimir Sikic 13
Next Page